Shengli Zhou

Mr. Shengli Zhou

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
SZShengli Zhou
Shengli Zhou
KTKaname Tsutsumiuchi
Kaname Tsutsumiuchi
RIRitsuko Imai
Ritsuko Imai
YMYukiko Miki
Yukiko Miki
AKAnna Kondo
Anna Kondo
Takashi OhtsukiTakashi Ohtsuki
Takashi Ohtsuki
Cancer cells have higher heat sensitivity compared to normal cells; therefore, hyperthermia is a promising approach for cancer therapy because of its ability to selectively kill cancer cells by heating them. However, the specific and rapid heating of tumor tissues remains challenging. This study investigated the potential of magnetic nanoparticles (MNPs) modified with tumor-homing peptides (THPs), specifically PL1 and PL3, for tumor-specific magnetic hyperthermia therapy. The synthesis of THP-modified MNPs involved the attachment of PL1 and PL3 peptides to the surface of the MNPs, which facilitated enhanced tumor cell binding and internalization. Cell specificity studies revealed an increased uptake of PL1- and PL3-MNPs by tumor cells compared to unmodified MNPs, indicating their potential for targeted delivery. In vitro hyperthermia experiments demonstrated the efficacy of PL3-MNPs in inducing tumor cell death when exposed to an alternating magnetic field (AMF). Even without exposure to an AMF, an additional ferroptotic pathway was suggested to be mediated by the nanoparticles. Thus, this study suggests that THP-modified MNPs, particularly PL3-MNPs, hold promise as a targeted approach for tumor-specific magnetic hyperthermia therapy.

6 January 2025 in Cells
Verified
Journal Article
Open access
PDF file
AFAbdul Basith Fithroni
Abdul Basith Fithroni
HIHaruki Inoue
Haruki Inoue
SZShengli Zhou
Shengli Zhou
THTaufik Fatwa Nur Hakim
Taufik Fatwa Nur Hakim
TTTakashi Tada
Takashi Tada
Eiji MatsuuraEiji Matsuura
Eiji Matsuura
Boron (B) neutron capture therapy (BNCT) is a novel non-invasive targeted cancer therapy based on the nuclear capture reaction 10B (n, alpha) 7Li that enables the death of cancer cells without damaging neighboring normal cells. However, the development of clinically approved boron drugs remains challenging. We have previously reported on self-forming nanoparticles for drug delivery consisting of a biodegradable polymer, namely, “AB-type” Lactosome® nanoparticles (AB-Lac particles)- highly loaded with hydrophobic B compounds, namely o-Carborane (Carb) or 1,2-dihexyl-o-Carborane (diC6-Carb), and the latter (diC6-Carb) especially showed the “molecular glue” effect. Here we present in vivo and ex vivo studies with human pancreatic cancer (AsPC-1) cells to find therapeutically optimal formulas and the appropriate treatment conditions for these particles. The biodistribution of the particles was assessed by the tumor/normal tissue ratio (T/N) in terms of tumor/muscle (T/M) and tumor/blood (T/B) ratios using near-infrared fluorescence (NIRF) imaging with indocyanine green (ICG). The in vivo and ex vivo accumulation of B delivered by the injected AB-Lac particles in tumor lesions reached a maximum by 12 h post-injection. Irradiation studies conducted both in vitro and in vivo showed that AB-Lac particles-loaded with either 10B-Carb or 10B-diC6-Carb significantly inhibited the growth of AsPC-1 cancer cells or strongly inhibited their growth, with the latter method being significantly more effective. Surprisingly, a similar in vitro and in vivo irradiation study showed that ICG-labeled AB-Lac particles alone, i.e., without any 10B compounds, also revealed a significant inhibition. Therefore, we expect that our ICG-labeled AB-Lac particles-loaded with 10B compound(s) may be a novel and promising candidate for providing not only NIRF imaging for a practical diagnosis but also the dual therapeutic effects of induced cancer cell death, i.e., “theranostics”.

11 February 2026 in Analytical Methods
Verified
Journal Article
Open access
PDF file
SZShengli Zhou
Shengli Zhou
HFHiroko Fukaya
Hiroko Fukaya
SWShunsuke Watanuki
Shunsuke Watanuki
WLWei Liu
Wei Liu
MYMaasa Yokomori
Maasa Yokomori
KYKeitaro Yoshimoto
Keitaro Yoshimoto
The development of fast, simple, and visual methods for detecting adenosine triphosphate (ATP) is crucial for point-of-care diagnostics and environmental monitoring. Colorimetric assays based on the integration of DNA aptamer-triggered hybridization chain reaction (HCR) with gold nanoparticles (AuNPs) offer high potential, but existing methods often suffer from prolonged detection times (e.g., >130 min). To address this limitation, this study systematically investigated and optimized the core parameters of the aptamer-triggered HCR system and its subsequent mixing conditions with AuNPs to achieve a rapid visual detection platform. The HCR kinetics were accelerated by the high concentrations of single-stranded DNA (ssDNA) components, particularly the H0 initiator, as well as by the critical presence of divalent magnesium ions (Mg2+), which also support the functionality of the aptamer. This optimization allowed for a degree of HCR progression comparable to the traditional 24-hour incubation to be achieved within just 60 minutes. Subsequently, recognizing the inherent trade-off between the high ssDNA concentration required for fast HCR and the AuNP dispersion stability, we optimized the mixing ratio between the HCR product and the AuNP solution. Under these optimized conditions, the assay demonstrated the capability for rapid visual detection of ATP at the 100 µM level within a total assay time of 15 minutes, representing a significant acceleration compared to previously reported methods. Further improvements in sensitivity are anticipated through future fine-tuning of AuNP parameters and the use of post-reaction salt aggregation enhancers.

5 January 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
SZShengli Zhou
Shengli Zhou
FYFurutani Yuji
Furutani Yuji
KYKei Yamashita
Kei Yamashita
SKSakuya Kako
Sakuya Kako
KWKazunori Watanabe
Kazunori Watanabe
Takashi OhtsukiTakashi Ohtsuki
Takashi Ohtsuki
Magnetic nanoparticles (MNPs) provide a platform for target detection because of their magnetic responsiveness to alternating magnetic fields (AMFs). We developed a detection method using MNPs modified with tumor-homing peptides (THPs), PL1 and PL3, which selectively bind to protein components enriched in malignant tissues. THP-MNPs were synthesized using maleimide-PEG-NHS linkers and characterized using transmission electron microscopy. Human glioblastoma cancer U87MG and normal tissue-derived HEK293 cells were incubated with THP-MNPs, and the magnetic signals were measured using a high-temperature superconducting quantum interference device (SQUID) magnetometer under an AMF (1.06 kHz). Dark-field microscopy confirmed the preferential binding of THP-MNPs to U87MG cells. In the absence of cells, THP-MNPs exhibited AMF-dependent signal enhancement, which correlated with particle size reduction due to THP release. This increase was completely suppressed in the presence of U87MG cells, indicating a strong THP-mediated interaction. PL3-MNPs exhibited superior discrimination between malignant and non-malignant cells. These results demonstrate that SQUID-based magnetic measurements using THP-MNPs enable rapid and label-free cancer cell detection.